Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.670
-0.160 (-4.18%)
Jan 23, 2026, 3:00 PM EST - Market open
MRVI Market Cap
MRVI has a market cap or net worth of $938.44 million as of January 23, 2026. Its market cap has increased by 11.19% in one year.
Market Cap
938.44M
Enterprise Value
1.06B
1-Year Change
11.19%
Ranking
Category
Stock Price
$3.67
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $938.44M, a decrease of -61.37%. That is a compound annual growth rate of -16.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 555.44M | 17.85% |
| Dec 31, 2025 | 471.32M | -39.03% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 1.03B |
| ARS Pharmaceuticals | 1.03B |
| Annexon | 1.02B |
| GH Research | 1.02B |
| Iovance Biotherapeutics | 996.39M |
| Ventyx Biosciences | 995.17M |
| Nanobiotix | 985.87M |
| Vir Biotechnology | 965.53M |